19937 results for «»
19937 results
Aoi Nishi
Osaka, Japan
Chiharu Moriyama
Osaka, Japan
Post-TAVI cardiac arrest associated to acute coronary occlusion: facing the storm to gain calm
26 Jan 2024
Observe this TAVI case featuring pulseless electrical activity due to an unforeseen acute occlusion of the right coronary artery, and discover the strategies employed to address and resolve this critical complication.
Authors :
Pretreatment with P2Y12 inhibitors in ST-segment elevation myocardial infarction - insights from the Bern-PCI Registry
26 Jan 2024
This study sought to compare outcomes between patients presenting with STEMI before and after the recent ESC guidelines for the management of ACS recommend against pre-treatment with P2Y12 inhibitors in STEMI patients.

Reviewer

Reviewer
Empowering European Healthcare Systems: RESIL-Card, an EU4Health Project, Launches to Enhance Cardiovascular Care Resilience
19 Jan 2024
Paris, 18 January 2024: The consortium and supporting partners that make up the RESIL-Card project kick-started the venture on 1st December 2023.
The 3-year project received a funding grant from the European Commission under the EU4Health Work Programme to strengthen European healthcare systems in providing continuity of care for...
Sumie Takao
Fukuoka, Japan
Yasuhiro Tanaka
Tokyo, Japan
#PCRTokyo 2026 Social Media Team
Tatsuo Takahashi
Tokyo, Japan
Publications by the PCR Tricuspid Focus Group
15 Jan 2024
Navigating the Future of Cardiovascular Health through In-Depth Insights
Discover cutting-edge tricuspid interventions with PCR Focus Group publications, exploring the latest breakthroughs and techniques in cardiovascular care. Join us in advancing the frontier of cardiac health.
Noriko Shiokawa
Kanagawa, Japan
Coronary physiology guidance vs conventional angiography for optimization of percutaneous coronary intervention: the AQVA-II Trial
24 Jan 2024
The primary aim of this study was to demonstrate the superiority of physiology-guided PCI, using either angiography or microcatheter-derived FFR, over conventional angiography-based PCI in complex high-risk indicated procedures (CHIPs) in obtaining a higher FFR post-PCI.

Reviewer
Rethinking false positive exercise electrocardiographic stress tests by assessing coronary microvascular function
24 Jan 2024
This study aims to compare the results of EST in patients reporting angina with those having non-obstructive coronary artery disease (ANOCA), against the reference standard of microvascular function.

Reviewer

Reviewer
Ali Kerem Yılmaz
Istanbul, Türkiye

Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score
13 Feb 2024
The study aim was to develop and validate a novel score for prediction of 1-year mortality and clinical outcomes through artificial intelligence (AI) application in patients undergoing M-TEER.

Reviewer

Reviewer
Kaoru Matsuura
Japan
HF/RV function & TR Educational Series
05 Feb 2024
In this series of tutorials, Karl-Philipp Rommel (Leipzig, Germany) shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.
Hemodynamic diagnosis of tricuspid regurgitation/right heart failure
Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure, starting in this first episode with the hemodynamic assessment.
In this video you will learn:
- to recognize the intricate relationship between symptoms and hemodynamics in (TR-related) right heart failure.
- to...
PCR Tricuspid Focus Group - referral meeting in Utrecht
23 Nov 2023
Join your peers for this meeting on 22 January 2025 in Utrecht, Netherlands!
Focus on aortic valves
22 Nov 2023 – From PCR London Valves 2023
Simon Redwood and Christopher Cook cover the top three highlights of the aortic track at #PCRLV 2023:
- LIVE and recorded cases showcasing procedures from simple to highly complex.
- Engaging discussions on TAV in TAV procedures to enhance our ability to effectively treat patients.
- Long-term data and late trial results...